Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP Implementation in Brazilian Transgender Women
NCT03220152Phase 4Unknown
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Jul 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Fundação Oswaldo Cruz. Status: unknown.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03220152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03220152.